Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 13835
Country/Region: Uganda
Year: 2015
Main Partner: Baylor College of Medicine
Main Partner Program: Children's Foundation
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $9,543,755 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,589,739
Care: Orphans and Vulnerable Children (HKID) $1,131,726
Care: TB/HIV (HVTB) $295,599
Care: Pediatric Care and Support (PDCS) $728,503
Laboratory Infrastructure (HLAB) $50,000
Health Systems Strengthening (OHSS) $0
Testing: HIV Testing and Counseling (HVCT) $946,483
Sexual Prevention: Other Sexual Prevention (HVOP) $306,172
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $543,255
Treatment: Adult Treatment (HTXS) $3,382,501
Treatment: Pediatric Treatment (PDTX) $569,777
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 2,886
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 15,978
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 295
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 1,622
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 5,659
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 31,172
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 348
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 1,927
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 9,188
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 50,699
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 9,188
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 50,699
CARE_NEW Aggregated Age/sex: <15 Female 2016 314
CARE_NEW Aggregated Age/sex: <15 Male 2016 274
CARE_NEW Aggregated Age/sex: 15+ Female 2016 5,342
CARE_NEW Aggregated Age/sex: 15+ Male 2016 2,900
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 8,830
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 8,830
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 8,830
FN_THER Aggregated Age: <18 2016 472
FN_THER Aggregated Age: 18+ 2016 744
FN_THER Number of clinically malnourished PLHIV who received therapeutic and/or supplementary food during the reporting period 2016 1,216
FN_THER Number of PLHIV who were nutritionally assessed and found to be clinically undernourished 2016 15,211
FN_THER Sum of Aggregated Age disaggregates 2016 1,216
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 6,654
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 20,310
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 5,024
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 15,320
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 50,664
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 154,624
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 36,531
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 111,505
HTS_TST By Test Result: Negative 2016 95,736
HTS_TST By Test Result: Negative 2016 292,058
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 98,873
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 301,759
HTS_TST Sum of Aggregated Age/Sex <15 2016 11,678
HTS_TST Sum of Aggregated Age/Sex <15 2016 35,630
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 87,195
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 266,129
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 98,873
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 301,759
HTS_TST Sum of Test Result disaggregates 2016 98,873
HTS_TST Sum of Test Result disaggregates 2016 301,759
HTS_TST_POS By Test Result: Positive 2016 3,137
HTS_TST_POS By Test Result: Positive 2016 9,701
LAB_ACC Number of PEPFAR-supported testing facilities (laboratories) that are recognized by national, regional, or international standards for accreditation or have achieved a minimal acceptable level towards attainment of such accreditation 2016 1
LAB_CAP By clinical laboratories 2016 24
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2016 24
OVC_ACC Number of active beneficiaries receiving support from PEPFAR OVC programs to access HIV services 2016 18,193
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2016 34,334
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 1,868
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 4,271
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 1,868
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 4,271
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 1,634
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 3,636
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 234
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 635
PMTCT_ARV Sum of New and Current disaggregates 2016 1,868
PMTCT_ARV Sum of New and Current disaggregates 2016 4,271
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2016 342
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 3,416
PMTCT_EID Sum of Infant Age disaggregates 2016 3,416
PMTCT_STAT By: Known positives at entry 2016 1,598
PMTCT_STAT By: Known positives at entry 2016 3,626
PMTCT_STAT By: Number of new positives identified 2016 270
PMTCT_STAT By: Number of new positives identified 2016 645
PMTCT_STAT Number of new ANC and L&D clients 2016 30,637
PMTCT_STAT Number of new ANC and L&D clients 2016 76,944
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 29,067
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 72,941
PMTCT_STAT Sum of Positives Status disaggregates 2016 1,868
PMTCT_STAT Sum of Positives Status disaggregates 2016 4,271
PP_PREV Age/sex: 10-14 Female 2016 8,401
PP_PREV Age/sex: 10-14 Male 2016 6,401
PP_PREV Age/sex: 15-19 Female 2016 14,841
PP_PREV Age/sex: 15-19 Female 2016 790
PP_PREV Age/sex: 15-19 Male 2016 12,819
PP_PREV Age/sex: 15-19 Male 2016 908
PP_PREV Age/sex: 20-24 Female 2016 21,909
PP_PREV Age/sex: 20-24 Female 2016 1,170
PP_PREV Age/sex: 20-24 Male 2016 14,744
PP_PREV Age/sex: 20-24 Male 2016 982
PP_PREV Age/sex: 25-49 Female 2016 31,683
PP_PREV Age/sex: 25-49 Female 2016 1,663
PP_PREV Age/sex: 25-49 Male 2016 24,474
PP_PREV Age/sex: 25-49 Male 2016 1,734
PP_PREV Age/sex: 50+ Female 2016 2,110
PP_PREV Age/sex: 50+ Female 2016 150
PP_PREV Age/sex: 50+ Male 2016 1,984
PP_PREV Age/sex: 50+ Male 2016 150
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2016 139,366
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2016 7,547
PP_PREV Sum of Age/Sex disaggregates 2016 139,366
PP_PREV Sum of Age/Sex disaggregates 2016 7,547
PP_PREV Total number of people in the target population 2016 348,403
PP_PREV Total number of people in the target population 2016 21,811
TB_ART Aggregated Age: <15 2016 49
TB_ART Aggregated Age: 15+ 2016 553
TB_ART Female 2016 385
TB_ART Known HIV-positive 2016 275
TB_ART Male 2016 217
TB_ART Sum of Aggregated Age disaggregates 2016 602
TB_ART Sum of Sex disaggregates 2016 602
TB_ART Sum of Test Status disaggregates 2016 275
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2016 752
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2016 602
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2016 3,544
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2016 47,155
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 9,188
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 50,699
TB_SCREEN Sex: Female 2016 33,106
TB_SCREEN Sex: Male 2016 17,593
TB_SCREEN Sum of Aggregated Age disaggregates 2016 50,699
TB_SCREEN Sum of Sex disaggregates 2016 50,699
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 50,699
TX_CURR Aggregated Age/Sex: 15+ Female 2016 2,485
TX_CURR Aggregated Age/Sex: 15+ Female 2016 14,015
TX_CURR Aggregated Age/Sex: 15+ Male 2016 5,368
TX_CURR Aggregated Age/Sex: 15+ Male 2016 30,484
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 8,476
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 48,036
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 7,853
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 44,499
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 7,853
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 44,499
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2016 3,774
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2016 7,938
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 12,229
TX_NEW Sum of Aggregated Age/Sex disaggregates 2016 11,712
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 8,548
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 10,061
Cross Cutting Budget Categories and Known Amounts Total: $1,250,000
Gender: Gender Based Violence (GBV) $500,000
Post GBV Care
Collection and Use of Gender-related Strategic Information
Monitoring and Evaluation
Gender: Gender Equality $250,000
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Monitoring and Evaluation
Increase gender-equitable access to income and productive resources, including education
Collection and Use of Gender-related Strategic Information
Monitoring and Evaluation
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Monitoring and Evaluation
Key Populations: Sex Workers $500,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention